Menu

Blog

Archive for the ‘biotech/medical’ category: Page 2169

May 11, 2018

Researchers find glycolysis links to gene transcription via NAD+

Posted by in categories: biotech/medical, food

A team of researchers at the University of Texas has found NAD+ synthesis and consumption integrate glucose metabolism and adipogenic transcription during adipocyte differentiation. In their paper published in the journal Science, the group describes their research into how glucose is converted into fat in the body and what they found. Sophie Trefely and Kathryn Wellen with the University of Pennsylvania and Drexel University, respectively, offer a Perspective piece on the work done by the team in Texas in the same journal issue.

As obesity rates continue to climb around the globe, scientists continue to explore why it is happening. In addition to studying the psychological aspects involved, scientists would also like to better understand why eating too much makes people gain weight. In this new effort, the researchers looked more closely into why consuming too much glucose causes the body to produce fat.

Prior research has shown that (NAD) is an important molecule that plays a role in a wide variety of physiological and pathological processes. Its oxidized form, NAD+, has also been found to act as a cofactor in metabolic pathways, and more importantly, perhaps, is consumed by various enzymes. Once consumed, NAD+ is broken down into nicotinamides and ADP-ribose. This, the researchers note, means that NAD+ must be resynthesized for normal cellular function to continue. They further note that some prior research has suggested that lower-than-normal levels of NAD+ can alter , leading in some cases to higher disease susceptibility.

Continue reading “Researchers find glycolysis links to gene transcription via NAD+” »

May 11, 2018

On life extension and risk aversion

Posted by in categories: biotech/medical, life extension

A discussion on whether or not extended lifespans might make us paranoid about every tiniest risk.


Some months back, I read “Sapiens: A Brief History of Humankind” by Yuval Noah Harari. It’s a really good book, though it did disappoint me significantly when, after discussing the past and the present of our species, the author began glancing towards possible futures. At that point, the impartiality required of a historian, which Harari had thus far managed to keep up more or less evenly throughout the book, gave way to a subtly implied pessimism pervading, among other things, his views on future rejuvenation biotechnology.

Honestly, I wasn’t expecting him to even touch upon the subject; I was pleasantly surprised, at least until I realized that his concerns, most of which were the usual ones you’d expect, seemed to make him inclined to see rejuvenation as a plague rather than a blessing.

Continue reading “On life extension and risk aversion” »

May 10, 2018

Early Time-Restricted Feeding Improves Insulin Sensitivity, Blood Pressure, and Oxidative Stress Even without Weight Loss in Men with Prediabetes

Posted by in category: biotech/medical

Sutton et al. conduct the first supervised controlled feeding trial to test whether intermittent fasting has benefits in humans in the absence of weight loss. Prediabetic men following a form of intermittent fasting called early time-restricted feeding improved their insulin sensitivity, blood pressure, and oxidative stress levels without losing weight.

Read more

May 10, 2018

Seeing is believing: How AI could prevent blindness for 415 million people (right now)

Posted by in categories: biotech/medical, information science, robotics/AI

When you take a picture of a cat and Google’s algorithms place it in a folder called “pets,” with no direction from you, you’re seeing the benefit of image recognition AI. The exact same technology is used by doctors to diagnose diseases on a scale never before possible by humans.

Diabetic retinopathy, caused by type two diabetes, is the fastest-growing cause of preventable blindness. Each of the more than 415 million people living with the disease risks losing their eyesight unless they have regular access to doctors.

In countries like India there are simply too many patients for doctors to treat. There are 4,000 diabetic patients for every ophthalmologist in India, where the US has one for every 1,500 patients.

Continue reading “Seeing is believing: How AI could prevent blindness for 415 million people (right now)” »

May 10, 2018

US commercial drones given green light

Posted by in categories: biotech/medical, drones, food, robotics/AI

Drones that monitor crops, control mosquito populations and deliver defibrillators are to be tested in US airspace.

Ten commercial drone projects have been selected to try out new ways for unmanned aircraft to be integrated into the skies.

They include Zipline, which currently offers a blood-delivery service in Rwanda, and Apple.

Continue reading “US commercial drones given green light” »

May 10, 2018

Doctors Replaced a Soldier’s Lost Ear Using a Wild Medical Technique

Posted by in categories: biotech/medical, materials

In a first for United States Army doctors, Burrage received an ear transplant that was grown from her own tissue inside her own body. A team, led by Lieutenant Colonel Owen Johnson III, the chief of plastic and reconstructive surgery at William Beaumont Army Medical Center in El Paso, Texas, harvested cartilage from Burrage’s ribs, carved it into the shape of an ear, and implanted it under the skin in her arm. There, it developed blood vessels, which Johnson says will allow Burrage to regain feeling in the ear once it’s healed. In an announcement released on Monday, Johnson called the operation a success.

Article continues below.

Read more

May 10, 2018

Self-navigating AI learns to take shortcuts: study

Posted by in categories: biotech/medical, robotics/AI

A computer programme modelled on the human brain learnt to navigate a virtual maze and take shortcuts, outperforming a flesh-and-blood expert, its developers said Wednesday.

While artificial intelligence (AI) programmes have recently made great strides in imitating human brain processing—everything from recognising objects to playing complicated board games—spatial navigation has remained a challenge.

Continue reading “Self-navigating AI learns to take shortcuts: study” »

May 10, 2018

The first smallpox treatment is one step closer to FDA approval

Posted by in categories: biotech/medical, terrorism

Upcoming anti-viral medication for smallpox…


As bioterrorism fears grow, the first treatment for smallpox is nearing approval.

Called tecovirimat, the drug stops the variola virus, which causes smallpox, from sending out copies of itself and infecting other cells. “If the virus gets ahead of your immune system, you get sick,” says Dennis Hruby, the chief scientific officer of pharmaceutical company SIGA Technologies, which took part in developing the drug. “If you can slow the virus down, your immune system will get ahead.”

Continue reading “The first smallpox treatment is one step closer to FDA approval” »

May 9, 2018

New Wearable Oral Sodium Sensor to Help Fight Hypertension

Posted by in categories: biotech/medical, wearables

Researchers from the Georgia Institute of Technology have built a flexible, wearable oral sodium sensor that could help monitor a person’s sodium intake.


A leading cause of hypertension is a person’s uncontrolled salt intake. This often results in high blood pressure and heart complications.

As a solution, the Georgia Institute of Technology researchers built the oral sodium sensor that could be easily worn in the mouth to monitor salt intake.

Continue reading “New Wearable Oral Sodium Sensor to Help Fight Hypertension” »

May 9, 2018

Future anti-aging drugs could flip a “metabolic switch” to mimic fasting

Posted by in categories: biotech/medical, life extension

Fasting has been found to have a range of health benefits, and appears to slow down the aging process. Now, researchers from MIT have found that fasting for just 24 hours is enough to improve the regeneration of a person’s intestinal stem cells, which naturally declines with age. Better yet, with the metabolic switch identified, in the future the effect could be mimicked with a drug.

As with stem cells in all parts of the body, intestinal stem cells are in charge of growing new cells in the organ. They maintain the lining of the intestine, which is shed and replaced every few days, fight off infection and repair damage to the tissue. But as is usually the case, these stem cells get less and less effective at their job with age.

Previous research has found that caloric restriction, or continual fasting, has a profound effect on health and longevity. These effects have been seen in mice, rats, monkeys, lemurs, and other animals, and although human studies haven’t really been conducted, it seems that we could also benefit from harnessing the diet. So the MIT team set out to study the effects of fasting on intestinal stem cells.

Read more